Compounded or brand-name GLP-1: an informed decision guide
Approved brand products and compounded preparations are not equivalent. A useful discussion starts with indication, medical need, product evidence, and options that can be filled legally for your location.
Five differences that change the decision
| Topic | Approved brand | Compounded preparation |
|---|---|---|
| FDA review | Finished product approved for specific indications. | Finished preparation is not approved. |
| Evidence | Trials of the studied product. | Cannot claim brand results as its own. |
| Presentation | Approved labeling defines presentation and use. | Prescription and instructions may vary by pharmacy. |
| Dispensing | Licensed pharmacy. | Licensed pharmacy under applicable requirements. |
| Cost | Depends on coverage, product, and manufacturer program. | Depends on prescription and pharmacy; evaluation is billed separately. |
Brand evidence is not a compounded promise
Published weight-loss percentages come from trials with defined products, doses, and follow-up protocols. They help explain the treatment studied but do not predict the outcome of a different preparation. Every result varies.
Still comparing?
Test the compounded option for one month, $199, before you commit
The Skeptics' Trial includes the physician evaluation and, only if a prescription is approved and the dispensing pharmacy can fulfill it for your location, one month of compounded semaglutide; the pharmacy confirms packaging and shipping details before fulfillment. No long-term commitment. A compounded preparation is a different product from Wegovy or Ozempic: not FDA-approved, not brand-identical, and results vary.
How the 30-day trial worksWhen a preparation may be considered
FDA states that compounding may be appropriate when an individual patient's medical need cannot be met by an available approved drug. That conclusion must be individualized. Cost, general preference, or convenience language does not replace the required clinical determination.
A calm decision checklist
- Confirm the diagnosis and indication.
- Ask whether an available approved option can meet the need.
- Review personal benefits, risks, and contraindications.
- Verify the pharmacy that would dispense any preparation.
- Get separate costs and a follow-up plan in writing.
For an expanded table, see our main compounded and brand-name GLP-1 comparison.
Expanded decision guide
Start by separating the categories
An FDA-approved brand product is a specific finished drug with product-specific labeling and reviewed evidence. A compounded GLP-1 preparation is made under a compounding pathway for an identified clinical circumstance. It is not FDA-approved, not brand-identical, results vary, and it should not be described with the approved product's outcome claims.
| Practical question | Approved product | Compounded preparation |
|---|---|---|
| What evidence applies? | The exact label and product-specific studies | The finished preparation has not received FDA premarket approval |
| Why might it be used? | It fits the indication and individual plan | A prescriber identifies a clinical rationale and separately confirms the applicable legal conditions |
| What must be verified? | Prescription, product, pharmacy, cost, and follow-up | All of those items plus the compounding reason and dispensing-pharmacy record |
Why compounding exists and how 503A fits
Compounding can address an individual need that an available approved product cannot meet. Under 503A, qualifying compounding may be performed by a licensed pharmacist in a state-licensed pharmacy or federal facility, or by a licensed physician. The clinic performs the medical evaluation but does not manufacture or dispense; any fulfillment depends on a dispensing pharmacy verified for the patient and location. If the significant-difference exception is relied on, the prescriber must determine and document that a change produces a significant difference for the identified patient. Changing a concentration or adding an ingredient does not establish that result automatically.
When each route may fit
An approved product may fit when its indication, product-specific studies, formulation, access, and risk profile align with the patient. A compounded preparation may be discussed when the prescriber identifies a relevant clinical rationale and lawful dispensing is possible. Clinical fit does not replace the separate compounding conditions. Either decision requires informed consent, side-effect planning, and follow-up.
Warning signs before payment
- No clinician reviews the full history before a prescription is promised.
- The pharmacy's legal name or licensing jurisdiction is withheld.
- The preparation is described as identical to an approved product.
- One document is presented as proof of every quality attribute or future lot.
- Medication, evaluation, renewal, and cancellation terms are not separated.
Primary and official source trail
Read each source for the exact product, population, date, method, and limitation. A source supports only the claim it actually studied or the policy it actually states.
Apply this checklist to New Hope
Every standard on this page is one we hold ourselves to: a $119 physician review with Dr. Anjmun Sharma, MD before any prescription decision, a named dispensing pharmacy you can verify for your location, transparent pricing with medication billed separately (compounded semaglutide from $166/month, tirzepatide from $233/month), and plain disclosure that compounded medications are not FDA-approved, not brand-identical, and that results vary. Telehealth care is available for eligible California patients.
See if you qualify, free 2-min quiz Check availability for your locationFrequently asked questions
Does a compounded GLP-1 have the same evidence as the brand drug?
No. Trials support the product and formulation studied. They do not establish effectiveness or predict the outcome of a different compounded preparation.
Is compounded semaglutide identical to Wegovy or Ozempic?
No. It is not FDA-approved, not brand-identical, and results vary by individual.
What matters besides price?
Indication, contraindications, availability of an approved drug, individual need, administration experience, follow-up, and the pharmacy that would dispense all matter.
Who dispenses a compounded preparation?
The licensed pharmacy, not the clinic, prepares and dispenses the prescription when applicable requirements are met.
How are costs separated?
The medical evaluation is $119 if care is available for your location. Medication is quoted separately before you proceed.
This article is educational and does not replace an individual medical evaluation. Do not start, stop, or change a medication without speaking with your health care professional.